These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32660502)

  • 21. Recent trends in early stage response to combination antiretroviral therapy in Australia.
    McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG;
    Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
    ; Berenguer J; Polo R; Aldeguer JL; Lozano F; Aguirrebengoa K; Arribas JR; Blanco JR; Boix V; Casado JL; Clotet B; Crespo M; Domingo P; Estrada V; García F; Gatell JM; González-García J; Gutiérrez F; Iribarren JA; Knobel H; Llibre JM; Locutura J; López JC; Miró JM; Moreno S; Podzamczer D; Portilla J; Pulido F; Ribera E; Riera M; Rubio R; Santos J; Sanz-Moreno J; Sanz J; Téllez MJ; Tuset M; Rivero A
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):544-56. PubMed ID: 26021186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.
    Cardoso SW; Luz PM; Velasque L; Torres TS; Tavares IC; Ribeiro SR; Moreira RI; Veloso VG; Moore RD; Grinsztejn B
    BMC Infect Dis; 2014 Dec; 14():699. PubMed ID: 25523385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trial.
    Katlama C; Clotet B; Plettenberg A; Jost J; Arasteh K; Bernasconi E; Jeantils V; Cutrell A; Stone C; Purdon S;
    HIV Med; 2001 Jan; 2(1):27-34. PubMed ID: 11737373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen.
    Varriano B; Sandler I; Loutfy M; Steinberg S; Smith G; Kovacs C; Brunetta J; Fletcher D; Knox D; Merkley B; Chang B; Tilley D; Acsai M; Crouzat F
    Int J STD AIDS; 2019 Jun; 30(7):680-688. PubMed ID: 31042101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
    Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
    Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.
    Venkatesh KK; DeLong AK; Kantor R; Chapman S; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM; Cu-Uvin S
    J Womens Health (Larchmt); 2013 Apr; 22(4):330-8. PubMed ID: 23531097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
    Brumme ZL; Chan KJ; Dong WW; Mo T; Wynhoven B; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
    AIDS; 2002 Sep; 16(14):1929-33. PubMed ID: 12351953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Revised guideline "Antiretroviral Treatment"].
    Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
    João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
    Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 10-year effectiveness of combination antiretroviral treatment in perinatally HIV-infected children participating in Thailand's National Access Program.
    Aurpibul L; Puthanakit T; Sudjaritruk T; Oberdorfer P; Chotecharoentanan T; Taejaroenkul S; Wongnum N; Sirisanthana V
    Antivir Ther; 2016; 21(3):261-5. PubMed ID: 26158783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin.
    Denoeud-Ndam L; Fourcade C; Ogouyemi-Hounto A; Azon-Kouanou A; d'Almeida M; Azondékon A; Alao MJ; Dossou-Gbété V; Afangnihoun A; Girard PM; Cot M; Zannou DM
    PLoS One; 2013; 8(3):e59446. PubMed ID: 23555035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) and Early-treated Perinatally HIV-infected Individuals: Improving Childrenʼs Actual Life with Novel Immunotherapeutic Strategies (EPIICAL) study groups
    AIDS; 2019 Jun; 33(7):1155-1165. PubMed ID: 30741823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.
    Wood E; Hogg RS; Yip B; Tyndall MW; Sherlock CH; Harrigan RP; O'Shaughnessy MV; Montaner JS
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):159-66. PubMed ID: 12045678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.